Login / Signup

Frequency of peripheral PD-1 + regulatory T cells is associated with treatment responses to PARP inhibitor maintenance in patients with epithelial ovarian cancer.

Jung-Yun LeeJung Chul KimMiran LeeJooHyang LeeYoo-Na KimYong Jae LeeSunghoon KimSang Wun KimSu-Hyung ParkJung-Yun Lee
Published in: British journal of cancer (2023)
Tregs, which have negative prognostic value for PARPi monotherapy.
Keyphrases
  • regulatory t cells
  • dendritic cells
  • combination therapy
  • dna damage
  • randomized controlled trial
  • open label
  • clinical trial
  • oxidative stress
  • immune response
  • replacement therapy
  • double blind
  • smoking cessation